Tiziana Life Sciences Ltd.: Tiziana Life Sciences Hosting Key Opinion Leader Virtual Event to Discuss the Intranasal Delivery of Foralumab in Multiple Sclerosis

Monday, March 14th @ 11 am ET, registration details belowNEW YORK, March 11, 2022 (GLOBE NEWSWIRE) -- Tiziana Life Sciences Ltd (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company enabling

Related Keywords

Boston ,Massachusetts ,United States ,India ,Toronto ,Ontario ,Canada ,Philadelphia ,Pennsylvania ,Irina Koffler ,Lawrence Steinman ,Neuromyelitis Optica ,Robertl Kroc ,Howardl Weiner ,Tarun Singhal ,Howard Weiner ,Hana Malik ,Tanuja Chitnis ,Brigham Pediatric Ms Center ,Professor Of Neurology At Harvard Medical School ,Imaging Program In Neurologic Diseases ,Tiziana Life Sciences Ltd Nasdaq ,Founder Of The Partners Multiple Sclerosis Center ,Stanford University Interdepartmental Program In Immunology ,Neurological Sciences ,Harvard Medical School ,University Of Toronto Medical School ,Tiziana Life Sciences ,International Pediatric Ms Workgroup ,Tiziana Life Sciences Ltd ,India Institute Of Medical Sciences ,Ann Romney Center ,Business Development ,Life Sciences Ltd ,Key Opinion Leader ,Clinical Update ,Multiple Sclerosis ,Landmark Study ,Massachusetts General Hospital ,Stanford Medicine ,Secondary Progressive Multiple Sclerosispositive ,Partners Multiple Sclerosis Center ,Neurologic Diseases ,Show Science ,Medical School ,Neurology Endowed ,Mass General Brigham Pediatric ,Mass General Hospital ,Toronto Medical School ,Harvard Medical ,International Pediatric ,Assistant Professor ,All India Institute ,Medical Sciences ,Norepinephrine Transporter ,Stanford University Interdepartmental Program ,Life Sciences ,Investor Relations ,Tiziana ,Life ,Ciences ,Posting ,Opinion ,Leader ,Irtual ,Event ,Iscuss ,Intranasal ,Delivery ,Foralumab ,Multiple ,Clerosis ,